Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Methods in Enzymology|January 13, 2004
Influenza virosomes in vaccine developmentAnke Huckriede, Laura Bungener, Toos Daemen, et al.Bioscience Reports|November 14, 2002
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMsLaura Bungener, Anke Huckriede, Jan Wilschut, et al.Rheumatology (Oxford, England)|January 6, 2017
Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active diseaseKarina de Leeuw, Laura Bungener, Caroline Roozendaal, et al.Vaccine|February 1, 2003
Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7Toos Daemen, Annelies Riezebos-Brilman, Laura Bungener, et al.Journal of Liposome Research|February 27, 2003
Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigensLaura Bungener, Jacqueline Idema, Wouter ter Veer, et al.Advanced Drug Delivery Reviews|November 25, 2004
Virosomes for antigen and DNA deliveryToos Daemen, Arjan de Mare, Laura Bungener, et al.Influenza and Other Respiratory Viruses|May 21, 2009
Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCsFelix Geeraedts, Laura Bungener, Judith Pool, et al.Vaccine|April 11, 2008
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protectionLaura Bungener, Felix Geeraedts, Wouter Ter Veer, et al.Vaccine|January 22, 2011
Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccinesHeng Liu, Laura Bungener, Wouter ter Veer, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2006
Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapyAnnelies Riezebos-Brilman, Arjan de Mare, Laura Bungener, et al.Pageof 2